Results demonstrated a confirmed overall response rate of 35% (95% CI, 24-46), all of which were partial responses. The Food and Drug Administration (FDA) has approved Emrelis ™ (telisotuzumab ...

Two patients present with pink plaques on different parts of their head and face. Can you correctly identify each case? An 81-year-old White man with a history of a renal transplant presented with ...

The median overall survival was 16.5 months with anlotinib plus penpulimab and 13.2 months with sorafenib. First-line treatment with anlotinib and penpulimab can improve survival outcomes when ...

With an increasing geographic footprint, it is important for clinicians to be able to recognize and treat coccidioidomycosis, ...

Recently we asked our readers for the best advice they’ve received as an NP or PA and what advice they would give to newly graduated NPs or PAs. Here are some of the words of wisdom on building ...

This month’s case involves 2 clinicians who assumed that if blood work had been normal in the past, it would remain normal.

Dr Jones served as the 11th PA Consultant to the US Army Surgeon General, where he helped military PA policy, expanding PA ...

Air pollutants, such as nitrogen oxide, nitrogen dioxide, and sulfur dioxide, were associated with taurine, inosine, and C38:4 phosphatidylethanolamine, respectively. HealthDay News — Exposure ...

Prescription stimulant misuse was less prevalent among women aged 35 to 64, but this same group saw an increase in the number of individuals dispensed these medications. Among patients prescribed ...

In an update to its guidelines for treating pediatric atopic dermatitis, the American Academy of Pediatrics noted that successful treatment involves the triad of maintenance skin care, topical ...